Damora Therapeutics (DMRA) Tax Provisions (2024 - 2026)
Damora Therapeutics' (DMRA) quarterly Tax Provisions came in at $42000.0 in Q1 2026, up 2000.0% YoY from $2000.0 in Q1 2025, and down 4.55% on a QoQ basis from $44000.0 in Q4 2025.
Damora Therapeutics (DMRA) Tax Provisions (2024 - 2026) Analysis & Trends
Damora Therapeutics (DMRA) has 3 years of Tax Provisions data on file, last reported at $42000.0 in Q1 2026.
- Quarterly Tax Provisions rose 2000.0% year-over-year to $42000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90000.0 (up 109.3% YoY) and the FY2025 annual result came in at $50000.0, up 21.95% from the prior year.
- Tax Provisions declined to $42000.0 in Q1 2026, from $44000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $44000.0 in Q4 2025 to a low of -$8000.0 in Q4 2024.
- A 3-year average of $19000.0 and a median of $7000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2025 — Tax Provisions sank 90.48% — and 2026, when it surged 2000.0%.
- Tracing DMRA's Tax Provisions over 3 years: stood at -$8000.0 in 2024, then jumped by 650.0% to $44000.0 in 2025, then decreased by 4.55% to $42000.0 in 2026.
- The last three Tax Provisions figures came in at $42000.0 (Q1 2026), $44000.0 (Q4 2025), and $4000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Damora Therapeutics | 1.92 Bn | 1.38 Bn | - | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 42,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 42,000.00 |